- Home
- STAA vs ATTO Comparison
STAA vs ATTO Comparison
Compare STAA & ATTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STAA | ATTO |
|---|---|---|
| Founded | 1982 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 1995 | 2026 |
Fundamental Metrics
Financial Performance| Metric | STAA | ATTO |
|---|---|---|
| Price | $21.76 | $15.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 5 |
| Target Price | $28.00 | ★ $42.20 |
| AVG Volume (30 Days) | ★ 928.5K | 417.4K |
| Earning Date | 11-04-2026 | 09-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $239,442,000.00 | N/A |
| Revenue This Year | $39.61 | N/A |
| Revenue Next Year | $7.86 | N/A |
| P/E Ratio | $82.69 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.59 | $14.23 |
| 52 Week High | $35.87 | $28.00 |
Technical Indicators
Market Signals| Indicator | STAA | ATTO |
|---|---|---|
| Relative Strength Index (RSI) | 47.63 | 33.03 |
| Support Level | $21.72 | N/A |
| Resistance Level | $22.97 | $18.38 |
| Average True Range (ATR) | 0.80 | 1.17 |
| MACD | 0.09 | -0.29 |
| Stochastic Oscillator | 64.83 | 15.34 |
Price Performance
Historical ComparisonAbout STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
About ATTO Attovia Therapeutics Inc. Common Stock
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.